Keros Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2019 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Keros Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q4 2024.
  • Keros Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -5.94K %, a 94.7% increase year-over-year.
  • Keros Therapeutics, Inc. annual Operating Margin for 2024 was -5.94K %, a 94.7% increase from 2023.
  • Keros Therapeutics, Inc. annual Operating Margin for 2023 was -113K %.
  • Keros Therapeutics, Inc. annual Operating Margin for 2021 was -280K %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -5.94K +107K +94.7% Oct 1, 2024 Dec 31, 2024
Q3 2024 -31.3K Jul 1, 2024 Sep 30, 2024
Q2 2024 -69.6K Apr 1, 2024 Jun 30, 2024
Q1 2024 -76.7K Jan 1, 2024 Mar 31, 2024
Q4 2023 -113K Oct 1, 2023 Dec 31, 2023
Q3 2020 -1.44K Jul 1, 2020 Sep 30, 2020
Q2 2020 -529 Apr 1, 2020 Jun 30, 2020
Q1 2020 -243 Jan 1, 2020 Mar 31, 2020
Q4 2019 -106 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.